Loading...
Biotest AG
BIESF•PNK
Healthcare
Biotechnology
$32.00
$0.00(0.00%)
Biotest AG (BIESF) Financial Performance & Income Statement Overview
Review Biotest AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.08%
↑ 6.08%
Operating Income Growth
-34.15%
↓ 34.15%
Net Income Growth
-79.21%
↓ 79.21%
Operating Cash Flow Growth
2355.56%
↑ 2355.56%
Operating Margin
13.01%
↑ 13.01%
Gross Margin
30.82%
↑ 30.82%
Net Profit Margin
3.64%
↑ 3.64%
ROE
4.98%
↑ 4.98%
ROIC
7.42%
↑ 7.42%
Biotest AG (BIESF) Income Statement & Financial Overview
Review Biotest AG's (BIESF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $203.50M | $150.70M | $156.80M | $215.20M |
| Cost of Revenue | $150.60M | $121.50M | $105.70M | $124.60M |
| Gross Profit | $52.90M | $29.20M | $51.10M | $90.60M |
| Gross Profit Ratio | $0.26 | $0.19 | $0.33 | $0.42 |
| R&D Expenses | $10.60M | $17.00M | $14.20M | $15.00M |
| SG&A Expenses | $28.80M | $14.80M | $21.40M | $23.20M |
| Operating Expenses | $29.50M | $36.50M | $25.50M | $38.20M |
| Total Costs & Expenses | $180.10M | $158.00M | $131.20M | $162.80M |
| Interest Income | $5.60M | $1.90M | $1.70M | $1.80M |
| Interest Expense | $11.80M | $9.50M | $10.00M | $12.50M |
| Depreciation & Amortization | $0.00 | $1.90M | $1.70M | $7.60M |
| EBITDA | $3.30M | -$5.40M | $27.30M | $54.60M |
| EBITDA Ratio | $0.02 | -$0.04 | $0.17 | $0.25 |
| Operating Income | $23.40M | -$7.30M | $25.60M | $52.40M |
| Operating Income Ratio | $0.11 | -$0.05 | $0.16 | $0.24 |
| Other Income/Expenses (Net) | -$21.40M | -$7.60M | -$8.30M | -$10.30M |
| Income Before Tax | $2.00M | -$14.90M | $17.30M | $42.10M |
| Income Before Tax Ratio | $0.010 | -$0.10 | $0.11 | $0.20 |
| Income Tax Expense | $5.60M | -$5.60M | $7.60M | $12.60M |
| Net Income | -$3.50M | -$9.30M | $9.70M | $29.50M |
| Net Income Ratio | -$0.02 | -$0.06 | $0.06 | $0.14 |
| EPS | -$0.09 | -$0.25 | $0.25 | $0.75 |
| Diluted EPS | -$0.09 | -$0.25 | $0.25 | $0.75 |
| Weighted Avg Shares Outstanding | $39.57M | $37.20M | $39.57M | $39.57M |
| Weighted Avg Shares Outstanding (Diluted) | $39.57M | $37.20M | $39.57M | $39.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan